Centene Corp. (CNC): Price and Financial Metrics

Centene Corp. (CNC): $86.21

1.60 (+1.89%)

POWR Rating

Component Grades














  • Growth is the dimension where CNC ranks best; there it ranks ahead of 97.34% of US stocks.
  • CNC's strongest trending metric is Sentiment; it's been moving up over the last 179 days.
  • CNC ranks lowest in Momentum; there it ranks in the 38th percentile.

CNC Stock Summary

  • With a market capitalization of $49,502,798,339, Centene Corp has a greater market value than 94.5% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for CNC is 4.7 -- better than 91.4% of US stocks.
  • CNC's price/sales ratio is 0.39; that's higher than the P/S ratio of merely 8.24% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Centene Corp, a group of peers worth examining would be JCI, HUM, COF, DG, and ECL.
  • Visit CNC's SEC page to see the company's official filings. To visit the company's web site, go to www.centene.com.

CNC Valuation Summary

  • In comparison to the median Healthcare stock, CNC's price/sales ratio is 97.36% lower, now standing at 0.3.
  • Over the past 240 months, CNC's EV/EBIT ratio has gone up 17.3.
  • CNC's price/earnings ratio has moved up 36.2 over the prior 240 months.

Below are key valuation metrics over time for CNC.

Stock Date P/S P/B P/E EV/EBIT
CNC 2021-08-31 0.3 1.4 51.0 23.6
CNC 2021-08-30 0.3 1.4 51.2 23.6
CNC 2021-08-27 0.3 1.4 51.8 23.9
CNC 2021-08-26 0.3 1.4 51.5 23.8
CNC 2021-08-25 0.3 1.4 51.5 23.8
CNC 2021-08-24 0.3 1.5 52.3 24.1

CNC Growth Metrics

    Its 2 year net income to common stockholders growth rate is now at -17.88%.
  • Its 5 year net income to common stockholders growth rate is now at 207.27%.
  • Its 4 year revenue growth rate is now at 234.47%.
Over the past 34 months, CNC's revenue has gone up $60,616,000,000.

The table below shows CNC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 125,982 4,205 1,347
2021-09-30 121,702 6,511 736
2021-06-30 118,386 3,757 720
2021-03-31 115,073 5,786 2,461
2020-12-31 111,115 5,503 1,808
2020-09-30 101,690 1,871 2,029

CNC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CNC has a Quality Grade of C, ranking ahead of 69.88% of graded US stocks.
  • CNC's asset turnover comes in at 1.689 -- ranking 4th of 133 Insurance stocks.
  • JRVR, CIA, and AXS are the stocks whose asset turnover ratios are most correlated with CNC.

The table below shows CNC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.689 0.114 0.062
2021-06-30 1.698 0.119 0.068
2021-03-31 1.669 0.136 0.167
2020-12-31 1.635 0.137 0.138
2020-09-30 1.666 0.138 0.157
2020-06-30 1.744 0.133 0.147

CNC Price Target

For more insight on analysts targets of CNC, see our CNC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $83.10 Average Broker Recommendation 1.43 (Moderate Buy)

CNC Stock Price Chart Interactive Chart >

Price chart for CNC

CNC Price/Volume Stats

Current price $86.21 52-week high $89.92
Prev. close $84.61 52-week low $59.67
Day low $83.56 Volume 1,972,800
Day high $86.39 Avg. volume 2,900,130
50-day MA $82.23 Dividend yield N/A
200-day MA $78.53 Market Cap 50.42B

Centene Corp. (CNC) Company Bio

Centene Corporation is a publicly traded managed care company based in St. Louis, Missouri. It serves as an intermediary for government-sponsored and privately insured health care programs. Centene ranked No. 24 on the 2021 Fortune 500 . (Source:Wikipedia)

CNC Latest News Stream

Event/Time News Detail
Loading, please wait...

CNC Latest Social Stream

Loading social stream, please wait...

View Full CNC Social Stream

Latest CNC News From Around the Web

Below are the latest news stories about Centene Corp that investors may wish to consider to help them evaluate CNC as an investment opportunity.

Select Medical (SEM) Q4 Earnings Beat on Higher Admissions

Select Medical's (SEM) fourth-quarter results reflect solid revenues driven by robust contributions from all its segments, partly offset by higher costs and expenses.

Yahoo | February 25, 2022

Centene CEO Michael Neidorff takes medical leave

The company named board member James Dallas as acting chairman, and said it expects to appoint a new CEO no later than the second quarter of this year. In December, the company had reached a deal with activist investment firm Politan Capital Management under which Neidorff was expected to retire this year after serving for a quarter of a century. Centene in July laid the groundwork for a succession plan when it established its office of the president and Neidorff, the CEO since 1996, said in public that he would not expect to be renewing his contract as the chief.

Yahoo | February 24, 2022


Centene Corporation (NYSE: CNC) ("Centene") announced today that its Board of Directors approved a request from Michael Neidorff, Chairman & Chief Executive Officer, for a medical leave of absence. James Dallas has been named Acting Chairman of the Board.

Yahoo | February 24, 2022

Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care

Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.

Yahoo | February 21, 2022

UnitedHealth Group (UNH) Bolsters Presence With Contract Win

UnitedHealth Group's (UNH) unit UnitedHealthcare receives a contract from the District of Columbia aimed at improving health outcomes of District Dual Choice program enrollees in the district.

Yahoo | February 18, 2022

Read More 'CNC' Stories Here

CNC Price Returns

1-mo 5.17%
3-mo -1.04%
6-mo 12.93%
1-year N/A
3-year 67.46%
5-year 116.34%
YTD 4.62%
2021 37.26%
2020 -4.52%
2019 9.05%
2018 14.29%
2017 78.52%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.542 seconds.